PH25498A - Transdermal flux enhancing compositions - Google Patents
Transdermal flux enhancing compositionsInfo
- Publication number
- PH25498A PH25498A PH36001A PH36001A PH25498A PH 25498 A PH25498 A PH 25498A PH 36001 A PH36001 A PH 36001A PH 36001 A PH36001 A PH 36001A PH 25498 A PH25498 A PH 25498A
- Authority
- PH
- Philippines
- Prior art keywords
- flux enhancing
- human
- transdermal flux
- transdermal
- enhancing compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US92564186A | 1986-10-31 | 1986-10-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
PH25498A true PH25498A (en) | 1991-07-24 |
Family
ID=25452022
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PH36001A PH25498A (en) | 1986-10-31 | 1987-10-29 | Transdermal flux enhancing compositions |
Country Status (24)
Country | Link |
---|---|
EP (1) | EP0271983B1 (el) |
JP (1) | JPH0757725B2 (el) |
KR (1) | KR900003697B1 (el) |
CN (1) | CN87107548A (el) |
AT (1) | ATE64306T1 (el) |
AU (1) | AU595948B2 (el) |
CA (1) | CA1338008C (el) |
DE (1) | DE3770786D1 (el) |
DK (1) | DK568187A (el) |
EG (1) | EG18324A (el) |
ES (1) | ES2031518T3 (el) |
GR (1) | GR3002137T3 (el) |
HU (1) | HU197993B (el) |
IE (1) | IE60379B1 (el) |
IL (1) | IL84269A (el) |
MX (1) | MX171058B (el) |
MY (1) | MY102980A (el) |
NO (1) | NO175617C (el) |
NZ (1) | NZ222346A (el) |
PH (1) | PH25498A (el) |
PT (1) | PT86023B (el) |
RU (2) | RU1836078C (el) |
YU (1) | YU46755B (el) |
ZA (1) | ZA878161B (el) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0306192B1 (en) * | 1987-08-28 | 1992-05-27 | Eli Lilly And Company | Permeation enhancement compositions |
US5196416A (en) * | 1987-08-28 | 1993-03-23 | Eli Lilly And Company | Transdermal flux-enhancing pharmaceutical compositions comprising azone, ethanol and water |
ES2051998T3 (es) * | 1988-02-29 | 1994-07-01 | Pfizer | Composiciones aumentadoras del flujo transdermal. |
CH679119A5 (el) * | 1988-05-13 | 1991-12-31 | Sandoz Ag | |
US5024843A (en) * | 1989-09-05 | 1991-06-18 | Alza Corporation | Oral hypoglycemic glipizide granulation |
US5023085A (en) * | 1989-11-29 | 1991-06-11 | Pfizer Inc. | Transdermal flux enhancers in combination with iontophoresis in topical administration of pharmaceuticals |
US5149719A (en) * | 1990-04-27 | 1992-09-22 | Minnesota Mining And Manufacturing Company | Composition for transdermal penetration of medicaments |
EP0577725A4 (en) * | 1991-03-29 | 1996-04-17 | Univ Florida | Targeted drug delivery via mixed phosphate derivatives |
RU2110261C1 (ru) * | 1992-12-31 | 1998-05-10 | Санкионг Индастриз Ко., Лтд. | Система трансдермальной доставки |
DE4341572C1 (de) * | 1993-12-07 | 1995-06-22 | Univ Dresden Tech | Zahnriemengetriebe |
TW304167B (el) * | 1995-01-30 | 1997-05-01 | Lilly Co Eli | |
GB2306885B (en) * | 1995-11-08 | 1999-07-14 | Reckitt & Colmann Prod Ltd | Supersaturated Pharmaceutical Compositions |
EP0849265A1 (de) * | 1996-12-20 | 1998-06-24 | HEUMANN PHARMA GmbH | Neue polymorphe Form von Doxazosin-Mesylat (Form II) |
JP2000143540A (ja) * | 1998-11-06 | 2000-05-23 | Bristol Myers Squibb Co | 非ステロイド系消炎鎮痛薬含有外用剤 |
WO2005039531A1 (en) | 2003-10-10 | 2005-05-06 | Antares Pharma Ipl Ag | Transdermal pharmaceutical formulation for minimizing skin residues |
US8980290B2 (en) | 2000-08-03 | 2015-03-17 | Antares Pharma Ipl Ag | Transdermal compositions for anticholinergic agents |
US6503894B1 (en) | 2000-08-30 | 2003-01-07 | Unimed Pharmaceuticals, Inc. | Pharmaceutical composition and method for treating hypogonadism |
JP4626202B2 (ja) * | 2003-07-16 | 2011-02-02 | 大正製薬株式会社 | ピロキシカム含有外用消炎鎮痛剤組成物 |
US8067399B2 (en) | 2005-05-27 | 2011-11-29 | Antares Pharma Ipl Ag | Method and apparatus for transdermal or transmucosal application of testosterone |
EP1909772A4 (en) * | 2005-08-05 | 2011-07-13 | Nuvo Res Inc | TRANSDERMAL DRUG FORMULATION |
PT1937276E (pt) | 2005-10-12 | 2013-02-21 | Besins Healthcare Luxembourg | Gel de testosterona melhorado e método para a sua utilização |
CA2646667C (en) | 2006-04-21 | 2014-03-11 | Antares Pharma Ipl Ag | Methods of treating hot flashes with formulations for transdermal or transmucosal application |
US20110294860A1 (en) * | 2008-12-17 | 2011-12-01 | Medrx Co., Ltd. | Aqueous oral preparation of stable amlodipine |
JP2014516962A (ja) * | 2011-05-16 | 2014-07-17 | パールマン,デール,エル. | 皮膚疾患の処置のための組成物及び方法 |
US8580286B2 (en) | 2012-03-16 | 2013-11-12 | Dale L. Pearlman | Compositions and methods for the treatment of skin diseases |
US20220378729A1 (en) | 2019-11-06 | 2022-12-01 | Smartech Topical, Inc. | Topical formulations of cyclooxygenase inhibitors and their use |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1538903A (en) * | 1975-04-11 | 1979-01-24 | Nelson Res & Dev | Carrier for a topically applied physiologically active agent or cosmetic agent |
US4405616A (en) * | 1975-06-19 | 1983-09-20 | Nelson Research & Development Company | Penetration enhancers for transdermal drug delivery of systemic agents |
US4316893A (en) * | 1975-06-19 | 1982-02-23 | Nelson Research & Development Co. | Vehicle composition containing 1-substituted azacycloalkan-2-ones |
BE843140A (fr) * | 1975-06-19 | 1976-10-18 | Aazacycloalcan-2-ones 1-substituees et compositions pharmaceutiques contenant ces composes a titre d'excipients | |
EP0127426A1 (en) * | 1983-05-23 | 1984-12-05 | Takeda Chemical Industries, Ltd. | Percutaneous pharmaceutical compositions for external use |
DK243084A (da) * | 1983-05-26 | 1984-11-27 | Takeda Chemical Industries Ltd | Perkutane farmaceutiske praeparater til udvortes brug |
US4537776A (en) * | 1983-06-21 | 1985-08-27 | The Procter & Gamble Company | Penetrating topical pharmaceutical compositions containing N-(2-hydroxyethyl) pyrrolidone |
US4557934A (en) * | 1983-06-21 | 1985-12-10 | The Procter & Gamble Company | Penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one |
-
1987
- 1987-10-17 MY MYPI87002939A patent/MY102980A/en unknown
- 1987-10-25 IL IL84269A patent/IL84269A/xx not_active IP Right Cessation
- 1987-10-27 DE DE8787309459T patent/DE3770786D1/de not_active Expired - Fee Related
- 1987-10-27 AT AT87309459T patent/ATE64306T1/de not_active IP Right Cessation
- 1987-10-27 EP EP87309459A patent/EP0271983B1/en not_active Expired - Lifetime
- 1987-10-27 ES ES198787309459T patent/ES2031518T3/es not_active Expired - Lifetime
- 1987-10-28 IE IE289687A patent/IE60379B1/en not_active IP Right Cessation
- 1987-10-28 YU YU196487A patent/YU46755B/sh unknown
- 1987-10-29 CN CN198787107548A patent/CN87107548A/zh active Pending
- 1987-10-29 CA CA000550540A patent/CA1338008C/en not_active Expired - Fee Related
- 1987-10-29 EG EG618/87A patent/EG18324A/xx active
- 1987-10-29 NZ NZ222346A patent/NZ222346A/xx unknown
- 1987-10-29 PT PT86023A patent/PT86023B/pt not_active IP Right Cessation
- 1987-10-29 PH PH36001A patent/PH25498A/en unknown
- 1987-10-30 DK DK568187A patent/DK568187A/da not_active Application Discontinuation
- 1987-10-30 MX MX026963A patent/MX171058B/es unknown
- 1987-10-30 NO NO874531A patent/NO175617C/no unknown
- 1987-10-30 KR KR1019870012096A patent/KR900003697B1/ko not_active IP Right Cessation
- 1987-10-30 ZA ZA878161A patent/ZA878161B/xx unknown
- 1987-10-30 AU AU80542/87A patent/AU595948B2/en not_active Ceased
- 1987-10-30 HU HU874898A patent/HU197993B/hu not_active IP Right Cessation
- 1987-10-30 JP JP62275581A patent/JPH0757725B2/ja not_active Expired - Lifetime
- 1987-10-30 RU SU874203579A patent/RU1836078C/ru active
-
1991
- 1991-06-13 GR GR91400807T patent/GR3002137T3/el unknown
- 1991-12-23 RU SU5010466A patent/RU2107515C1/ru active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EG18324A (en) | Transdermal flux enhancing compositions | |
IE890642L (en) | Transdermal flux enhancing compositions | |
IS1262B6 (is) | Ný samsetning efnis | |
ATE41772T1 (de) | Polymethoxybenzyl-piperazin-derivate, verfahren zu ihrer herstellung und diese derivate enthaltende pharmazeutische zusammensetzungen. | |
DK259387D0 (da) | Steroide forbindelser, der er virksomme mod kraeft og obesitet | |
KR830009776A (ko) | 세포 보호 유도방법 | |
KR920011486A (ko) | 항종양제 | |
JPS54125663A (en) | Carcinostatic agent and novel compound having carcinostatic activity |